FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Antimicrob Agents Chemother / Emergence of Resistance to Macrolides and Rifampin in Clinic...
Antimicrobial agents and chemotherapy2018; 63(1); e01714-18; doi: 10.1128/AAC.01714-18

Emergence of Resistance to Macrolides and Rifampin in Clinical Isolates of Rhodococcus equi from Foals in Central Kentucky, 1995 to 2017.

Abstract: The objective of this study was to determine the prevalence of strains resistant to macrolides and rifampin over time in clinical samples from foals submitted to diagnostic laboratories in central Kentucky. We performed a retrospective observational study of all clinical samples from foals that were submitted to veterinary diagnostic laboratories in Kentucky between January 1995 and December 2017. Samples were included if the bacterium was cultured and tested for susceptibility to erythromycin or rifampin. susceptibility testing to erythromycin was available for 2,169 isolates of , while susceptibility testing to both erythromycin and rifampin was available for 1,681 isolates. Rifampin resistance was first detected in 2000, and erythromycin resistance was first detected in 2004. Between 1995 and 2006, the proportion of resistant isolates of was 0.7% for erythromycin and 2.3% for rifampin. There was a significant ( < 0.001) increase in the proportion of resistant between 2007 and 2017, with 13.6% of isolates being resistant to erythromycin and 16.1% being resistant to rifampin. Between 2007 and 2017, isolates of resistant to erythromycin or rifampin were significantly less likely to be isolated from feces than from the respiratory tract, other soft tissues, or musculoskeletal infections. The considerable increase in the prevalence of isolates of resistant to macrolides and rifampin since 2007 is of concern for both human and animal health.
Copyright © 2018 American Society for Microbiology.
Get Full Text
Publication Date: 2018-12-21 PubMed ID: 30373803PubMed Central: PMC6325176DOI: 10.1128/AAC.01714-18Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article studies the increase in resistance to macrolides and rifampin in strains of Rhodococcus equi, a bacterium affecting foals, and found a significant increase in the prevalence of antibiotic resistance over a 22-year period in central Kentucky.

Research Objective and Methodology

  • The primary objective of this study was to examine how the prevalence of Rhodococcus equi strains resistant to macrolides and rifampin has increased over time.
  • To achieve this, the researchers conducted a retrospective observational study using clinical samples from foals, submitted to veterinary diagnostic laboratories in central Kentucky, between January 1995 and December 2017.
  • The samples were included if Rhodococcus equi bacterium was present and tested for susceptibility to either erythromycin (a macrolide) or rifampin.

Results and Analysis

  • Of the samples studied, susceptibility testing to erythromycin was available for 2,169 Rhodococcus equi isolates. Testing for both erythromycin and rifampin was available for 1,681 isolates.
  • Rifampin resistance was first detected in the year 2000, and erythromycin resistance was first detected in 2004.
  • Between 1995 and 2006, there was a low proportion of resistant isolates – 0.7% for erythromycin and 2.3% for rifampin.
  • A significant spike in antibiotic resistance occurred between 2007 and 2017, with 13.6% of isolates showing resistance to erythromycin and 16.1% showing resistance to rifampin.
  • Furthermore, isolates of Rhodococcus equi resistant to erythromycin or rifampin were significantly less likely to be isolated from feces compared to the respiratory tract, other soft tissues, or musculoskeletal infections between 2007 and 2017.

Conclusion and Implications

  • The study concluded that there’s a high rate of increase in the prevalence of Rhodococcus equi isolates, resistant to macrolides and rifampin, particularly after 2007.
  • This increase in antibiotic resistance is a cause of concern not just for the health of the animals, but it could potentially impact human health as well. Further research is likely needed to explore the possible reasons behind this drastic increase and to devise strategies to control and manage this threat.

Cite This Article

APA
Huber L, Giguère S, Slovis NM, Carter CN, Barr BS, Cohen ND, Elam J, Erol E, Locke SJ, Phillips ED, Smith JL. (2018). Emergence of Resistance to Macrolides and Rifampin in Clinical Isolates of Rhodococcus equi from Foals in Central Kentucky, 1995 to 2017. Antimicrob Agents Chemother, 63(1), e01714-18. https://doi.org/10.1128/AAC.01714-18

Publication

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
NlmUniqueID: 0315061
Country: United States
Language: English
Volume: 63
Issue: 1
PII: e01714-18

Researcher Affiliations

Huber, Laura
  • Department of Large Animal Medicine, University of Georgia, Athens, Georgia, USA laura.huber16@hotmail.com.
Giguère, Steeve
  • Department of Large Animal Medicine, University of Georgia, Athens, Georgia, USA.
Slovis, Nathan M
  • Hagyard Equine Medical Institute, Lexington, Kentucky, USA.
Carter, Craig N
  • Veterinary Diagnostic Laboratory, University of Kentucky, Lexington, Kentucky, USA.
Barr, Bonnie S
  • Rood and Riddle Equine Hospital, Lexington, Kentucky, USA.
Cohen, Noah D
  • Department of Large Animal Clinical Sciences, Texas A&M University, College Station, Texas, USA.
Elam, Justine
  • Hagyard Equine Medical Institute, Lexington, Kentucky, USA.
Erol, Erdal
  • Veterinary Diagnostic Laboratory, University of Kentucky, Lexington, Kentucky, USA.
Locke, Stephan J
  • Veterinary Diagnostic Laboratory, University of Kentucky, Lexington, Kentucky, USA.
Phillips, Erica D
  • Veterinary Diagnostic Laboratory, University of Kentucky, Lexington, Kentucky, USA.
Smith, Jacqueline L
  • Veterinary Diagnostic Laboratory, University of Kentucky, Lexington, Kentucky, USA.

MeSH Terms

  • Actinomycetales Infections / drug therapy
  • Actinomycetales Infections / epidemiology
  • Actinomycetales Infections / microbiology
  • Actinomycetales Infections / veterinary
  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Azithromycin / pharmacology
  • Clarithromycin / pharmacology
  • Drug Resistance, Multiple, Bacterial / drug effects
  • Drug Resistance, Multiple, Bacterial / genetics
  • Equidae
  • Erythromycin / pharmacology
  • Feces / microbiology
  • Horses
  • Kentucky / epidemiology
  • Microbial Sensitivity Tests
  • Musculoskeletal Diseases / drug therapy
  • Musculoskeletal Diseases / epidemiology
  • Musculoskeletal Diseases / microbiology
  • Musculoskeletal Diseases / veterinary
  • Prevalence
  • Respiratory System / drug effects
  • Respiratory System / microbiology
  • Rhodococcus equi / drug effects
  • Rhodococcus equi / genetics
  • Rhodococcus equi / growth & development
  • Rhodococcus equi / isolation & purification
  • Rifampin / pharmacology
  • Soft Tissue Infections / drug therapy
  • Soft Tissue Infections / epidemiology
  • Soft Tissue Infections / microbiology
  • Soft Tissue Infections / veterinary

References

This article includes 18 references
  1. Giguère S, Cohen ND, Chaffin MK, Slovis NM, Hondalus MK, Hines SA, Prescott JF. Diagnosis, treatment, control, and prevention of infections caused by Rhodococcus equi in foals.. J Vet Intern Med 2011 Nov-Dec;25(6):1209-20.
    doi: 10.1111/j.1939-1676.2011.00835.xpubmed: 22092608google scholar: lookup
  2. Yamshchikov AV, Schuetz A, Lyon GM. Rhodococcus equi infection.. Lancet Infect Dis 2010 May;10(5):350-9.
    doi: 10.1016/S1473-3099(10)70068-2pubmed: 20417417google scholar: lookup
  3. Reuss SM, Chaffin MK, Cohen ND. Extrapulmonary disorders associated with Rhodococcus equi infection in foals: 150 cases (1987-2007).. J Am Vet Med Assoc 2009 Oct 1;235(7):855-63.
    doi: 10.2460/javma.235.7.855pubmed: 19793018google scholar: lookup
  4. Fines M, Pronost S, Maillard K, Taouji S, Leclercq R. Characterization of mutations in the rpoB gene associated with rifampin resistance in Rhodococcus equi isolated from foals.. J Clin Microbiol 2001 Aug;39(8):2784-7.
    doi: 10.1128/JCM.39.8.2784-2787.2001pmc: PMC88239pubmed: 11473992google scholar: lookup
  5. Kenney DG, Robbins SC, Prescott JF, Kaushik A, Baird JD. Development of reactive arthritis and resistance to erythromycin and rifampin in a foal during treatment for Rhodococcus equi pneumonia.. Equine Vet J 1994 May;26(3):246-8.
    doi: 10.1111/j.2042-3306.1994.tb04379.xpubmed: 8542848google scholar: lookup
  6. Takai S, Takeda K, Nakano Y, Karasawa T, Furugoori J, Sasaki Y, Tsubaki S, Higuchi T, Anzai T, Wada R, Kamada M. Emergence of rifampin-resistant Rhodococcus equi in an infected foal.. J Clin Microbiol 1997 Jul;35(7):1904-8.
    pmc: PMC229871pubmed: 9196223doi: 10.1128/jcm.35.7.1904-1908.1997google scholar: lookup
  7. Venner M, Kerth R, Klug E. Evaluation of tulathromycin in the treatment of pulmonary abscesses in foals.. Vet J 2007 Sep;174(2):418-21.
    doi: 10.1016/j.tvjl.2006.08.016pubmed: 17045497google scholar: lookup
  8. Venner M, Rödiger A, Laemmer M, Giguère S. Failure of antimicrobial therapy to accelerate spontaneous healing of subclinical pulmonary abscesses on a farm with endemic infections caused by Rhodococcus equi.. Vet J 2012 Jun;192(3):293-8.
    doi: 10.1016/j.tvjl.2011.07.004pubmed: 21924651google scholar: lookup
  9. Venner M, Reinhold B, Beyerbach M, Feige K. Efficacy of azithromycin in preventing pulmonary abscesses in foals.. Vet J 2009 Feb;179(2):301-3.
    doi: 10.1016/j.tvjl.2007.10.002pubmed: 18023599google scholar: lookup
  10. Collignon P, Powers JH, Chiller TM, Aidara-Kane A, Aarestrup FM. World Health Organization ranking of antimicrobials according to their importance in human medicine: A critical step for developing risk management strategies for the use of antimicrobials in food production animals.. Clin Infect Dis 2009 Jul 1;49(1):132-41.
    doi: 10.1086/599374pubmed: 19489713google scholar: lookup
  11. Anastasi E, Giguère S, Berghaus LJ, Hondalus MK, Willingham-Lane JM, MacArthur I, Cohen ND, Roberts MC, Vasquez-Boland JA. Novel transferable erm(46) determinant responsible for emerging macrolide resistance in Rhodococcus equi.. J Antimicrob Chemother 2016 Jun;71(6):1746.
    doi: 10.1093/jac/dkw080pubmed: 26957491google scholar: lookup
  12. Riesenberg A, Feßler AT, Erol E, Prenger-Berninghoff E, Stamm I, Böse R, Heusinger A, Klarmann D, Werckenthin C, Schwarz S. MICs of 32 antimicrobial agents for Rhodococcus equi isolates of animal origin.. J Antimicrob Chemother 2014 Apr;69(4):1045-9.
    doi: 10.1093/jac/dkt460pubmed: 24275117google scholar: lookup
  13. Giguère S, Hondalus MK, Yager JA, Darrah P, Mosser DM, Prescott JF. Role of the 85-kilobase plasmid and plasmid-encoded virulence-associated protein A in intracellular survival and virulence of Rhodococcus equi.. Infect Immun 1999 Jul;67(7):3548-57.
    pmc: PMC116543pubmed: 10377138doi: 10.1128/IAI.67.7.3548-3557.1999google scholar: lookup
  14. Giguère S, Lee E, Williams E, Cohen ND, Chaffin MK, Halbert N, Martens RJ, Franklin RP, Clark CC, Slovis NM. Determination of the prevalence of antimicrobial resistance to macrolide antimicrobials or rifampin in Rhodococcus equi isolates and treatment outcome in foals infected with antimicrobial-resistant isolates of R equi.. J Am Vet Med Assoc 2010 Jul 1;237(1):74-81.
    doi: 10.2460/javma.237.1.74pubmed: 20590498google scholar: lookup
  15. Burton AJ, Giguère S, Sturgill TL, Berghaus LJ, Slovis NM, Whitman JL, Levering C, Kuskie KR, Cohen ND. Macrolide- and rifampin-resistant Rhodococcus equi on a horse breeding farm, Kentucky, USA.. Emerg Infect Dis 2013 Feb;19(2):282-5.
    doi: 10.3201/eid1902.121210pmc: PMC3559061pubmed: 23347878google scholar: lookup
  16. Jacks SS, Giguère S, Nguyen A. In vitro susceptibilities of Rhodococcus equi and other common equine pathogens to azithromycin, clarithromycin, and 20 other antimicrobials.. Antimicrob Agents Chemother 2003 May;47(5):1742-5.
    doi: 10.1128/AAC.47.5.1742-1745.2003pmc: PMC153307pubmed: 12709351google scholar: lookup
  17. McNeil MM, Brown JM. Distribution and antimicrobial susceptibility of Rhodococcus equi from clinical specimens.. Eur J Epidemiol 1992 May;8(3):437-43.
    doi: 10.1086/599374pubmed: 1397208google scholar: lookup
  18. Landis JR, Koch GG. The measurement of observer agreement for categorical data.. Biometrics 1977 Mar;33(1):159-74.
    doi: 10.2307/2529310pubmed: 843571google scholar: lookup

Citations

This article has been cited 16 times.
  1. Swanner KD, Patel R, Nguyen TT, Patel FN, Magadia R, Rifai AO, Davenport M. A Rare Presentation of Rhodococcus Equi Bacteremia as a Result of Right Upper Arm Cellulitis: A Case Report and Literature Review.. Cureus 2023 Apr;15(4):e38295.
    doi: 10.7759/cureus.38295pubmed: 37255906google scholar: lookup
  2. Rakowska A, Marciniak-Karcz A, Bereznowski A, Cywińska A, Żychska M, Witkowski L. Less Typical Courses of Rhodococcus equi Infections in Foals.. Vet Sci 2022 Oct 31;9(11).
    doi: 10.3390/vetsci9110605pubmed: 36356082google scholar: lookup
  3. Lord J, Carter C, Smith J, Locke S, Phillips E, Odoi A. Antimicrobial resistance among Streptococcus equi subspecies zooepidemicus and Rhodococcus equi isolated from equine specimens submitted to a diagnostic laboratory in Kentucky, USA.. PeerJ 2022;10:e13682.
    doi: 10.7717/peerj.13682pubmed: 36164606google scholar: lookup
  4. Narváez SÁ, Fernández I, Patel NV, Sánchez S. Novel Quantitative PCR for Rhodococcus equi and Macrolide Resistance Detection in Equine Respiratory Samples.. Animals (Basel) 2022 May 3;12(9).
    doi: 10.3390/ani12091172pubmed: 35565598google scholar: lookup
  5. Cohen ND, Flores-Ahlschewde P, Gonzales GM, Kahn SK, da Silveira BP, Bray JM, King EE, Blair CC, Bordin AI. Fecal concentration of Rhodococcus equi determined by quantitative polymerase chain reaction of rectal swab samples to differentiate foals with pneumonia from healthy foals.. J Vet Intern Med 2022 May;36(3):1146-1151.
    doi: 10.1111/jvim.16438pubmed: 35475581google scholar: lookup
  6. Nielsen SS, Bicout DJ, Calistri P, Canali E, Drewe JA, Garin-Bastuji B, Gonzales Rojas JL, Gortázar C, Herskin M, Michel V, Miranda Chueca MÁ, Padalino B, Pasquali P, Roberts HC, Spoolder H, Ståhl K, Velarde A, Viltrop A, Winckler C, Baldinelli F, Broglia A, Kohnle L, Alvarez J. Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): antimicrobial-resistant Rhodococcus equi in horses.. EFSA J 2022 Feb;20(2):e07081.
    doi: 10.2903/j.efsa.2022.7081pubmed: 35136423google scholar: lookup
  7. Patterson Rosa L, Mallicote MF, MacKay RJ, Brooks SA. Ion Channel and Ubiquitin Differential Expression during Erythromycin-Induced Anhidrosis in Foals.. Animals (Basel) 2021 Nov 25;11(12).
    doi: 10.3390/ani11123379pubmed: 34944156google scholar: lookup
  8. Zakia L, Shaw S, Bonomelli N, O'Sullivan S, Zur Linden A, Dubois M, Baird J, Guest B. Hematuria in a 3-month-old filly with an internal umbilical abscess and internal iliac artery aneurysm.. Can Vet J 2021 Aug;62(8):877-881.
    pubmed: 34341604
  9. Erol E, Scortti M, Fortner J, Patel M, Vázquez-Boland JA. Antimicrobial Resistance Spectrum Conferred by pRErm46 of Emerging Macrolide (Multidrug)-Resistant Rhodococcus equi.. J Clin Microbiol 2021 Sep 20;59(10):e0114921.
    doi: 10.1128/JCM.01149-21pubmed: 34319806google scholar: lookup
  10. Álvarez-Narváez S, Huber L, Giguère S, Hart KA, Berghaus RD, Sanchez S, Cohen ND. Epidemiology and Molecular Basis of Multidrug Resistance in Rhodococcus equi.. Microbiol Mol Biol Rev 2021 May 19;85(2).
    doi: 10.1128/MMBR.00011-21pubmed: 33853933google scholar: lookup
  11. Bordin AI, Cohen ND, Giguère S, Bray JM, Berghaus LJ, Scott B, Johnson R, Hook M. Host-directed therapy in foals can enhance functional innate immunity and reduce severity of Rhodococcus equi pneumonia.. Sci Rep 2021 Jan 28;11(1):2483.
    doi: 10.1038/s41598-021-82049-ypubmed: 33510265google scholar: lookup
  12. Álvarez-Narváez S, Giguère S, Cohen N, Slovis N, Vázquez-Boland JA. Spread of Multidrug-Resistant Rhodococcus equi, United States.. Emerg Infect Dis 2021 Feb;27(2):529-537.
    doi: 10.3201/eid2702.203030pubmed: 33496218google scholar: lookup
  13. Harvey AB, Bordin AI, Rocha JN, Bray JM, Cohen ND. Opsonization but not pretreatment of equine macrophages with hyperimmune plasma nonspecifically enhances phagocytosis and intracellular killing of Rhodococcus equi.. J Vet Intern Med 2021 Jan;35(1):590-596.
    doi: 10.1111/jvim.16002pubmed: 33326149google scholar: lookup
  14. Rakowska A, Cywinska A, Witkowski L. Current Trends in Understanding and Managing Equine Rhodococcosis.. Animals (Basel) 2020 Oct 18;10(10).
    doi: 10.3390/ani10101910pubmed: 33081047google scholar: lookup
  15. Álvarez-Narváez S, Giguère S, Berghaus LJ, Dailey C, Vázquez-Boland JA. Horizontal Spread of Rhodococcus equi Macrolide Resistance Plasmid pRErm46 across Environmental Actinobacteria.. Appl Environ Microbiol 2020 Apr 17;86(9).
    doi: 10.1128/AEM.00108-20pubmed: 32169935google scholar: lookup
  16. Mourenza Á, Gil JA, Mateos LM, Letek M. A Novel Screening Strategy Reveals ROS-Generating Antimicrobials That Act Synergistically against the Intracellular Veterinary Pathogen Rhodococcus equi.. Antioxidants (Basel) 2020 Jan 28;9(2).
    doi: 10.3390/antiox9020114pubmed: 32012850google scholar: lookup
Subscribe to our newsletter
Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.